Catabasis Pharma (CATB) Tops Q3 EPS by 2c

Catabasis Pharma (NASDAQ: CATB) reported Q3 EPS of ($0.31), $0.02 better than the analyst estimate of ($0.33).

For earnings history and earnings-related data on Catabasis Pharma (CATB) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery